How to get a free gallium-68 PSMA-11 PET/CT scan (and yes, there IS a catch)

A research team at the University of California, Los Angeles (UCLA) is seeking participants for a randomized, Phase III, clinical trial of the utility of 68Ga-PSMA-11 PET/CT molecular imaging for planning of salvage radiotherapy after first-line treatment for localized prostate cancer. … READ MORE …

tPSA, cPSA, %fPSA and risk for diagnosis with and death from prostate cancer

Data from a series of > 1,200 Danish patients, all referred by their primary primary care physicians to a single, specialized urology practice, seems to confirm what has long been suspected about the relative values of total and complex PSA levels in the diagnosis of prostate cancer. … READ MORE …

Is baseline free serum T a factor in appropriate management on active surveillance?

Analysis of data from a cohort of 154 Chilean men with prostate cancer, all being monitored on active surveillance, suggests that free serum testosterone levels (but not total testosterone levels) may be able to help to predict which of these men will go on to need active treatment. … READ MORE …

Old and newer tests and risks for prostate cancer; can you avoid inappropriate biopsy?

We now have five approved tests that can (at least in theory) help a man — and his doctors — to decide whether he is at sufficient risk for clinically significant prostate cancer that he should go get a biopsy. But how good are they really? … READ MORE …

Does smoking history predict PSA levels in a clinically significant manner?

A new paper published on line in the Journal of Urology suggests that the PSA and %free PSA levels of current smokers and former smokers may be statistically significantly impacted compared to those of men who have very rarely or never smoked.

Please donate free prostate cancer books for the newly diagnosed

Terry Herbert has started a potentially valuable new resource on the Yananow web site through which experienced patients can distribute books and other educational resources that they no longer need to newly diagnosed patients. … READ MORE …

PCA3, PSA, and free PSA in prediction of prostate cancer risk

A new study has suggested that, although the PCA3 test is slightly better than the total PSA test in prediction of risk for a positive biopsy finding, it is not necessarily always better than the free PSA test. … READ MORE …